Skip to the main content.

Waldenstrom Macroglobulinemia

PHASE 2

Case Studies

Here you can edit the background of the section

Overview

Our client hired us to provide Concierge travel support to an expansion cohort with Waldenstrom Macroglobulinemia, a rare white blood cell cancer. These patients, about 50 in total, were to receive an investigational radiotherapy treatment. 

What our clients didn’t immediately recognize: the highly complicated travel ramifications of the treatment. 

Upon conducting our customary pre-support needs assessment just weeks before FPI, our Concierge team identified the heightened risks that patients receiving the radioactive therapy would pose to their families and the general public — revealing for the sponsor the significant impact and limitations this posed on patient travel. 

In response, and to our client’s great relief, BBK designed and implemented a comprehensive, highly customizable and scalable travel and accommodation program to ensure secure physical distancing and that enabled seamless study continuity.   

 

Clover_Logo
Radioactive_Road-Sign

Challenges 

  • A short two-week period to identify and institute solutions 

  • Patients, many of whom would be traveling long distances and potentially internationally, would need to maintain six feet of distance for about a week post-treatment (precluding the option of air travel during that period)

  • A relatively quick travel turnaround for a second infusion, meaning most patients would need to be housed — with specified precautionary measures — for anywhere from one night up to a full two continuous months

  • Because of treatment-related fatigue, patients needed comprehensive support for daily living activities including meals, laundry, companionship and the ability for both the patient and caregiver to travel beyond the confines of their accommodations

  • A need for sites to implement a comprehensive, customized program from the moment of patient consent



 

Solutions

Through our TCNTM Arrive service, we created a comprehensive  and scalable long-term stay program, inclusive of the following elements: 

  • Specialized ground transportation van service to allow six-foot distancing between the passenger and driver. 

  • Accommodations that provided a private entrance, kitchenette, grocery and/or meal delivery, in-room laundry, a secondary room for caregivers and outdoor “walkability” to support ongoing well-being

  • Specialized medical cleaning service to remove the risk to facility cleaning staff

  • And, finally, to facilitate site staff communication and understanding about the program, we created materials and special site trainings. 

 

  • Calendar_ICON 2 Weeks To design and launch a complex travel and accommodation program

TCN-Arrive_Logo_TM

Impact

BBK made it possible for sites and patients to comply with the protocol — recognizing and solving the unique challenges at hand — all in a very short two-week timeframe. 

We implemented a program to meet every patient’s complex needs, enabling them to remain study compliant. 

BBK valued and protected the health of the patients, the patients’ families and the public at large — while allowing the study to enroll, progress and proceed without delay. 

 

Client Quote

Download the PDF version of this case study.

Subscribe to stay connected

Share this page:

Familial Amyloid Polyneuropathy — Neurology and Gene Therapy — Phase 3

case-studies-icon Case Studies

October 12, 2021

Pediatric Spinal Muscular Atrophy — Neurology and Rare Disease — Phase 2

case-studies-icon Case Studies

December 13, 2021

Major Depressive Disorder — Mental Health — Pivotal Phase 3 Study

case-studies-icon Case Studies

February 5, 2022

BBK Worldwide, LLC
117 Kendrick St., Suite 600
Needham, MA 02494 United States

        Terms & Conditions  Privacy Policy

        © 2023 BBK Worldwide. BBK Worldwide is a Publicis Health company.

        Facebook LinkedIn YouTube
        Facebook LinkedIn YouTube

        Terms & Conditions  Privacy Policy

        © 2023 BBK Worldwide. BBK Worldwide is a Publicis Health company.